Biosimilars are delivering on their cost-saving potential, reducing biologic medication costs and expanding treatment options. However, there are hurdles that hinder optimal biosimilar use, potentially jeopardizing their long-term viability in the healthcare system. _x000D_
_x000D_
_x000D_
_x000D_
Examining these challenges through real-world examples and case studies is essential to ensure biosimilars continue to play a significant role in overall healthcare affordability and access.
